Research Article

Preparation of Folate-Conjugated Pluronic F127/Chitosan Core-Shell Nanoparticles Encapsulating Doxorubicin for Breast Cancer Treatment

Table 1

Particle sizes and zeta potentials of pluronic micelles, chitosan nanoparticles, and folate-conjugated chitosan nanoparticles in the absence and presence of DOX.

ConditionParticle diameter (nm)% intensityZeta potential (mV)pH

Nanoparticles
 (i) Micelles 3 2 . 6 ± 2 . 1 81.9 4 . 8 ± 1 . 3 7.12
 (ii) Micelles with SDS 2 2 . 9 ± 0 . 3 73.7 1 1 . 4 ± 0 . 6 7.06
 (iii) Chitosan nanoparticles 3 4 . 1 ± 7 . 1 94.4 6 . 2 ± 3 . 6 4.70
 (iv) Folate-conjugated chitosan nanoparticles 4 1 . 3 ± 6 . 5 96.3 8 . 3 ± 1 . 1 4.74
DOX-loaded Nanoparticles
 (i) DOX-loaded micelles 3 3 . 7 ± 1 . 0 53.1 4 . 4 ± 0 . 8 7.07
 (ii) DOX-loaded micelles with SDS 2 0 . 3 ± 1 . 0 55.6 3 . 8 ± 0 . 8 7.03
 (iii) DOX-loaded chitosan nanoparticles 3 0 . 9 ± 1 . 7 96.3 1 0 . 6 ± 2 . 9 4.69
 (iv) DOX-loaded folate-conjugated chitosan nanoparticles 3 7 . 4 ± 2 . 0 94.9 1 2 . 9 ± 2 . 3 4.71